State Of Wyoming Ngm Biopharmaceuticals Inc Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$10.58 - $17.5 $2,317 - $3,832	-219 Reduced 89.75%	25 $0
Q1 2022 May 13, 2022	SELL	$13.81 - $18.6 $61,937 - $83,421	-4,485 Reduced 94.84%	244 $4,000
Q4 2021 Feb 11, 2022	BUY	$17.26 - $22.02 $71,922 - $91,757	4,167 Added 741.46%	4,729 $84,000
Q3 2021 Feb 11, 2022	SELL	$20.15 - $26.19 $6,145 - $7,987	-305 Reduced 35.18%	562 $12,000
Q2 2021 Feb 11, 2022	BUY	$15.06 - $30.03 $12,996 - $25,915	863 Added 21575.0%	867 $17,000
Q1 2021 Feb 08, 2022	BUY	$24.99 - $31.93 $99 - $127	4 New	4 $0

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.